alpha 1- and beta-adrenergic receptors are co-regulated during both noradrenergic denervation and hyperinnervation.
Changes in the density of alpha 1- and beta-adrenergic receptors were studied following denervation of rat cerebral cortex and hyperinnervation of cerebellum and motor trigeminal nucleus, caused by neonatal 6-hydroxydopamine treatment. Four well-defined thalamic projection zones to cortex were studied separately using tissue punch methodology. Both alpha 1- and beta-adrenergic receptors were unevenly distributed in motor, sensory, visual and auditory cortex. The density of alpha 1-adrenergic receptors correlated better with the norepinephrine content of the punches (r = 0.62) than did the density of beta-adrenergic receptors (r = 0.38). Noradrenergic denervation increased both alpha 1- and beta-adrenergic receptor density in almost all cortical areas studied, however the percentage increase was larger for beta- than alpha 1-adrenergic receptors. The change in receptor density was largest in visual cortex and smallest in somatosensory cortex for both receptor sub-types. Noradrenergic hyperinnervation caused a 15-18% decrease in both alpha 1- and beta-adrenergic receptor density in the motor trigeminal nucleus of the pons, but did not change the density of either receptor type in the cerebellum. In general, following either noradrenergic denervation or hyperinnervation the change in alpha 1-adrenergic receptor density was correlated (r = 0.64, P less than 0.005) with the change in beta-adrenergic receptor density in each region, suggesting that these different receptor sub-types are under similar control mechanisms.
Sutin
J
J
Minneman
K P
KP
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000502:physiology*; D002531:Cerebellum / Q000502:physiology; D002540:Cerebral Cortex / Q000502:physiology; D006892:Hydroxydopamines / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology*; D016627:Oxidopamine; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D014278:Trigeminal Nuclei / Q000502:physiology
D006892:Hydroxydopamines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D016627:Oxidopamine; D009638:Norepinephrine